SARS-CoV-2 Therapeutics Development
Led by researcher Kurt Zatloukal, focused on developing therapeutics to block SARS-CoV-2 infections and replication, particularly by inhibiting the...
Led by researcher Kurt Zatloukal, focused on developing therapeutics to block SARS-CoV-2 infections and replication, particularly by inhibiting the...
Pharma Holdings, led by Johnny I. Ryvoll in Norway, sought regulatory advice from EATRIS regarding the development of a nasal spray formulation for...
Alexander Jerman from Sferogen, a pre-clinical stage biotech company in Slovenia, sought regulatory advice regarding the development of their...
Led by Prof. Amadeu Llebaria from Barcelona, Spain, this project aimed to explore the binding properties of two families of antiviral compounds...
Dr. Séverine Padiolleau from France led a project, supported by ISIDORe, aimed at developing new diagnostic probes for Lyme borreliosis, a...
Dr. Leonardo Alonso from Argentina, with support from Instruct-ERIC and EMBL Hamburg, led a project to explore the effect of deamidation at position...
Dr. Jeremy Keown, from the United Kingdom, collaborated with Instruct-ERIC and VIB VZW in Brussels through the ISIDORe project to generate...
Enteroviruses cause a range of diverse diseases in humans, like polio or viral myocarditis. While there is a vaccine available for polio, the...
The University of Buea in Cameroon, in collaboration with European research infrastructures ERINHA and IGBMC (an Instruct-ERIC member), undertook a...
In response to the 2022 Monkeypox outbreak in non-endemic regions, Coris BioConcept, in partnership with INMI, initiated the development of a...